Veterans Nature Therapy (Vet Hike)

NCT ID: NCT03997344

Last Updated: 2021-06-14

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 26 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2019-05-10
• Study Completion Date: 2020-03-01

Brief Summary

This pilot study evaluates the feasibility of conducting a study to evaluate the impact of nature exposure/hiking in groups on symptoms of posttraumatic stress disorder in Veterans. Participants will be randomized to one of two groups: 1) nature hikes and 2) urban hikes.

Detailed Description

Objectives and hypothesis: Posttraumatic stress disorder (PTSD) is a tragically common problem among US Military Veterans. Current treatment options for PTSD are not uniformly effective and dropout rates are high. Treatment approaches that are evidence-based, effective, and acceptable to Veterans are needed. Nature therapy is a promising, low-cost intervention, yet there are few rigorous studies that have evaluated it as a therapeutic intervention in Veterans with PTSD.

The specific aims of this study are to lay the ground work for a full-scale study by assessing the feasibility and acceptability of: i) recruitment, screening, and data collection methods; and ii) the nature hiking and urban hiking control group interventions. The investigators hypothesize that the interventions will be feasible and the recruitment, screening, and data collection methods will be acceptable.

Key eligibility criteria for this two-arm pilot randomized controlled trial include being a Veterans with PTSD, physical fitness/ability sufficient to walk for at least 2 hours, and willingness to complete assessments. Eligible individuals will be randomized to one of two groups: 1) nature hiking group, 2) urban hiking group. The investigators will enroll up to 60 individuals, to randomize up to 15 participants per group. Note that the number enrolled and randomized are not expected to be the same since he investigators anticipate some individuals who enroll will be determined not to be eligible based on responses to the baseline questionnaire. Individuals randomized to groups 1 or 2 will be invited to participate in six hikes of 2-4 hours in duration, over approximately 12 weeks. Individuals will be asked to complete questionnaires at baseline and weekly for 12 weeks, and then again at 24 weeks. The primary outcomes for this study relate to feasibility and acceptability. The investigators will collect information on time to recruit the sample, retention and survey completion at each time point, and attendance at hikes. A secondary aim is to ascertain changes in PTSD symptoms (which will serve as the primary outcome of the full-scale trial), secondary outcomes (e.g., quality of life) and mediators of the intervention, including factors such as depression, perceived stress, affect, loneliness, anxiety, social connectedness, rumination, and nature connection.

Conditions

Posttraumatic Stress Disorders

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: SUPPORTIVE_CARE
• Blinding Strategy: NONE

Study Groups

Nature hiking

Group hikes in a natural setting (e.g., park, wilderness area)

Group Type: EXPERIMENTAL

Group nature hikes

Intervention Type: BEHAVIORAL

Six group nature hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.

Urban hikes

Group hikes in a urban setting (e.g., downtown area)

Group Type: ACTIVE_COMPARATOR

Group urban hikes

Intervention Type: BEHAVIORAL

Six group urban hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.

Interventions

Group nature hikes

Six group nature hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.

Intervention Type: BEHAVIORAL

Group urban hikes

Six group urban hikes will be offered once every other week. Total duration of intervention is 12 weeks. Hikes will be co-lead by two experienced hike leaders.

Intervention Type: BEHAVIORAL

Other Intervention Names

Nature hikes; Urban hikes

Eligibility Criteria

Inclusion Criteria

• U.S. Military Veteran;
• Active PTSD symptoms based on the PCL-5;
• No diagnosis of schizophrenia, bipolar disorder, or other psychotic disorders (based on self-report);
• Low risk of suicide (based on responses to the MINI Suicidal module);
• No inpatient admission in last 3 months (based on self-report);
• No current alcohol disorder/dependence (based on having a score<16 on the 10-item self-administered AUDIT questionnaire);
• No evidence of drug-related problems (based on having a score <3 on the DAST-10)
• Capable of safely participating in hikes as evidenced by no "yes's" on the Physical Activity Readiness Questionnaire (or approval of their primary care physician) and individual assertion that they can walk at least 2 hours at an easy to moderate effort with breaks;
• Willing to be randomized to one of two groups and complete all study procedures;
• Able to provide written informed consent to participate.

Exclusion Criteria

• Schizophrenia, bipolar disorder or other psychotic disorder

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

VA Puget Sound Health Care System

FED

Sponsor Role: collaborator

Recreational Equipment, Inc. (REI)

UNKNOWN

Sponsor Role: collaborator

University of Washington

OTHER

Sponsor Role: lead

Responsible Party

Gregory Bratman

Assistant Professor: College of the Environment

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Alyson Littman, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Washington

Locations

VA Puget Sound Health Care System

Seattle, Washington, United States

Countries

United States

References

Littman AJ, Bratman GN, Lehavot K, Engel CC, Fortney JC, Peterson A, Jones A, Klassen C, Brandon J, Frumkin H. Nature versus urban hiking for Veterans with post-traumatic stress disorder: a pilot randomised trial conducted in the Pacific Northwest USA. BMJ Open. 2021 Sep 23;11(9):e051885. doi: 10.1136/bmjopen-2021-051885.

Reference Type: DERIVED

PMID: 34556516 (View on PubMed)

Other Identifiers

STUDY00006745

Identifier Type: -

Identifier Source: org_study_id